Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $99.3, a high estimate of $106.00, and a low estimate of $89.00. Marking an ...
The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin.
The retail tie-up, RxSmartSaver, could help customers access GoodRx savings services for branded treatments at nearly 2,200 ...
Continuous glucose monitors (CGMs) are wearable technologies that track blood sugar in real time and help patients with type ...
Health Panels follows the lead of competitors by offering blood tests that users can schedule and review within the Oura app.
Stuart Lancaster's reign as Connacht head coach begins with a 26-15 win over Benetton in the United Rugby Championship at the Dexcom Stadium.
ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...
Oura Health makes a pricey smart ring that busy executives, celebrities and others use to track health measures like their ...
In a further comparison using DPP-4i/SU as the reference, the GLP-1 RA/SGLT2i combination therapy had the greatest effect in ...
The province deserves an enormous amount of kudos for going out there and getting Lancaster. Showing that level of ambition – and actually delivering on it – is a real statement of intent and shows ...
Qualcomm laid out its AI vision at the Snapdragon Summit — the ecosystem of you will extend our voices in new modalities with ...
Recent evidence reveals that more patients could benefit from receiving a continuous glucose monitoring prescription as part of diabetes care from their primary provider.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback